Subsequent research has further elaborated that APOL1 mutations inherited in a recessive manner confer a striking 17-fold increased risk of progression from FSGS to end-stage renal disease (ESRD) among AAs, with podocyte injury recognized as a key pathogenic mechanism [28]. Here, APOL1 is linked to focal segmental glomerulosclerosis.